Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.
Saved in:
| Title: | Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation. |
|---|---|
| Authors: | Claiborne, John Preston1 (AUTHOR), Tsai, Hua-Ling2 (AUTHOR), Ghiaur, Gabriel1 (AUTHOR), Smith, B. Douglas1 (AUTHOR), Gojo, Ivana1 (AUTHOR), DeZern, Amy E.1 (AUTHOR), Ambinder, Alex J.1 (AUTHOR), Jain, Tania1 (AUTHOR), Prince, Gabrielle T.1 (AUTHOR), Gondek, Lukasz P.1 (AUTHOR), Karantanos, Theodoros1 (AUTHOR), Dalton, W. Brian1 (AUTHOR), Levis, Mark J.1 (AUTHOR), Webster, Jonathan A.1 (AUTHOR) jwebst17@jhmi.edu |
| Source: | Leukemia & Lymphoma. Apr2026, Vol. 67 Issue 5, p1066-1079. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
